Clarithromycin and Brilinta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clarithromycin (clarithromycin) and Brilinta (ticagrelor). Common drug interactions include gastrointestinal haemorrhage among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Clarithromycin and Brilinta. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Clarithromycin?

Clarithromycin has active ingredients of clarithromycin. It is often used in sinusitis. eHealthMe is studying from 45,044 Clarithromycin users. Check the latest studies of Clarithromycin.

What is Brilinta?

Brilinta has active ingredients of ticagrelor. It is often used in stent. eHealthMe is studying from 22,469 Brilinta users. Check the latest studies of Brilinta.

On Aug, 02, 2026

21 people who take Clarithromycin and Brilinta together, and have interactions are studied.

Clarithromycin and Brilinta drug interactions.

What are the common drug interactions of Clarithromycin and Brilinta, by gender? *:

female:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haematemesis (vomiting of blood)
Haemoglobin decreased
Helicobacter infection (helicobacter pylori (h. pylori) infects stomach)
Nausea (feeling of having an urge to vomit)
Peptic ulcer haemorrhage (peptic ulcer bleeding)
Chronic kidney disease
Renal failure (kidney dysfunction)
Allergy to animal
Depression

male:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Osteonecrosis (death of bone)
Osteoporosis (bones weak and more likely to break)
Anaemia (lack of blood)
Renal failure (kidney dysfunction)
Duodenal ulcer
Haemoglobin decreased
Haemorrhage (bleeding)
Blood creatinine increased

What are the common drug interactions of Clarithromycin and Brilinta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anaemia (lack of blood)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Asthenia (weakness)
Bone density decreased
Chronic kidney disease
Decreased activity
Depression
Emotional distress
Gait disturbance

50-59:

Duodenal ulcer
Haemoglobin decreased
Haemorrhage (bleeding)
Chronic kidney disease
Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
Nephrogenic anaemia (anaemia due to kidney disease)
Nephropathy (damage to or disease of a kidney)
Renal failure (kidney dysfunction)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))

60+:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haematemesis (vomiting of blood)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Blood creatinine increased
Coronary artery restenosis (recurrence of narrowing of artery)
Depression
Emotional distress
Headache (pain in head)
Hypertension (high blood pressure)

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 23.81%
Gastric Ulcer (stomach ulcer): 5 people, 23.81%
Cardiac Disorder: 4 people, 19.05%
Hiv Infection: 4 people, 19.05%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 3 people, 14.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 14.29%
High Blood Cholesterol: 3 people, 14.29%
Bone Disorder: 2 people, 9.52%
Chest Pain: 2 people, 9.52%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Clarithromycin and Brilinta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously